LUMOS PHARMA, INC. - COM (LUMO)

Historical Portfolio Holders from Q1 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
2.09M
Holdings value Q3 2024
$8.08M
Value change Q3 2024
+$438K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
28
Number of buys Q3 2024
4
Number of sells Q3 2024
-19
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.09M $8.08M +$438K $3.87 28
2024 Q2 2.08M $4.82M -$286K $2.32 35
2024 Q1 2.18M $6.14M -$538K $2.82 35
2023 Q4 2.37M $7.52M -$233K $3.18 36
2023 Q3 2.44M $8.05M +$72.9K $3.30 33
2023 Q2 2.39M $7.9M +$530K $3.30 34
2023 Q1 2.23M $7.4M -$643K $3.31 34
2022 Q4 2.36M $8.58M -$534K $3.61 36
2022 Q3 2.51M $22.2M +$1.76M $8.85 30
2022 Q2 2.32M $17.9M -$855K $7.70 33
2022 Q1 2.48M $23.3M -$1.87M $9.40 31
2021 Q4 2.7M $18.7M -$1.21M $6.93 31
2021 Q3 2.87M $27.3M -$3.43M $9.51 30
2021 Q2 3.2M $32.1M -$1.16M $10.00 33
2021 Q1 3.31M $38.8M -$8.02M $11.70 33
2020 Q4 3.77M $135M +$4.56M $35.71 43
2020 Q3 3.63M $50.2M +$825K $13.82 33
2020 Q2 3.56M $58.7M +$5.04M $16.49 36
2020 Q1 3.28M $27.9M +$27.7M $8.50 40